This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
VERO Stock Likely to Get Support From New Regulatory Nod in Australia
by Zacks Equity Research
The latest approval for Venus Concept in Australia reinforces its position as a global player in the aesthetic technology space.
Venus Concept's (VERO) Latest Supply Deal to Aid its Business
by Zacks Equity Research
Venus Concept (VERO) announces an exclusive strategic supply arrangement with Skin Laundry Holdings, Inc.
Venus Concept (VERO) Expands Global Reach With New Partnerships
by Zacks Equity Research
Venus Concept (VERO) expects its deals to fetch continued success in both the United Kingdom and India.
Venus Concept (VERO) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Venus Concept (VERO) delivered earnings and revenue surprises of -100% and 9.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Illumina (ILMN) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Illumina (ILMN) delivered earnings and revenue surprises of -9.52% and 4.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Accuray (ARAY) delivered earnings and revenue surprises of 33.33% and 4.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ReWalk Robotics (RWLK) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
ReWalk (RWLK) delivered earnings and revenue surprises of -75% and 32.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Glaukos (GKOS) delivered earnings and revenue surprises of -88.64% and 7.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept (VERO) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Venus Concept (VERO) delivered earnings and revenue surprises of -30% and 2.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Globus Medical (GMED) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Globus Medical (GMED) delivered earnings and revenue surprises of -8.70% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alphatec (ATEC) delivered earnings and revenue surprises of -48.28% and 4.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept (VERO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Venus Concept (VERO) delivered earnings and revenue surprises of 33.33% and 0.41%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: SunOpta, Citi Trends, Organogenesis, Tapestry and Venus Concept
by Zacks Equity Research
Zacks.com featured highlights include: SunOpta, Citi Trends, Organogenesis, Tapestry and Venus Concept
Forget Bargains, Play 5 Stocks with Rising P/E Instead
by Sanghamitra Saha
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Venus Concept (VERO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Venus Concept (VERO) delivered earnings and revenue surprises of 71.43% and 6.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Venus Concept (VERO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Venus Concept (VERO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: Venus Concept (VERO)
by Zacks Equity Research
Venus Concept (VERO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Venus Concept (VERO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Venus Concept (VERO) delivered earnings and revenue surprises of -37.50% and 0.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept (VERO) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Venus Concept (VERO) delivered earnings and revenue surprises of 25.00% and -21.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept (VERO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Venus Concept (VERO) delivered earnings and revenue surprises of -8.33% and 2.70%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Venus Concept (VERO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: STNG, SNCR, VERO and JAGX
by Zacks Equity Research
Zacks.com featured highlights include: STNG, SNCR, VERO and JAGX